Toxicology Reagent DRI® Cotinine CLIA Non-Waived For Clinical Chemistry Analyzers

Name: Toxicology Reagent
Brand: DRI®

REAGENT, IMMUNOASSAY DRI COTININE 500ML D/S

McKesson #

1254870

Manufacturer #

0395

Brand

DRI®

Manufacturer

Microgenics

Country of Origin

Unknown

Application

Toxicology Reagent

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Clinical Chemistry Analyzers

Form

Ready-to-Use Liquid

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Urine Sample

Specialty

Toxicology

Storage Requirements

Requires Refrigeration

Test Category

Drugs of Abuse

Test Method

Homogeneous Enzyme Immunoassay (HEIA)

Test Name

Cotinine

UNSPSC Code

41116007

Volume

500 mL

The DRI® Cotinine Assay is an in vitro diagnostic medical device intended for the qualitative and semiquantitative determination of Cotinine in human urine at a cutoff level of 500 ng/mL
This assay is intended as an aid in the detection of cotinine after use or exposure to tobacco products
The DRI Cotinine Assay is a liquid, ready-to-use homogeneous enzyme immunoassa
Analyzers capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymatic rates at 340 nm and timing the reaction accurately can be used to perform this assay